NO20010654L - Ny anvendelse av taxoidderivater - Google Patents

Ny anvendelse av taxoidderivater

Info

Publication number
NO20010654L
NO20010654L NO20010654A NO20010654A NO20010654L NO 20010654 L NO20010654 L NO 20010654L NO 20010654 A NO20010654 A NO 20010654A NO 20010654 A NO20010654 A NO 20010654A NO 20010654 L NO20010654 L NO 20010654L
Authority
NO
Norway
Prior art keywords
new use
taxoid derivatives
taxoid
derivatives
new
Prior art date
Application number
NO20010654A
Other languages
English (en)
Other versions
NO20010654D0 (no
NO327296B1 (no
Inventor
Marie-Christine Bissery
Patricia Vrignaud
Simon Roberts
Clive Brealey
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98115401A external-priority patent/EP0982027A1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20010654D0 publication Critical patent/NO20010654D0/no
Publication of NO20010654L publication Critical patent/NO20010654L/no
Publication of NO327296B1 publication Critical patent/NO327296B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20010654A 1998-08-17 2001-02-07 Ny medisinsk anvendelse av 4α-acetoksy-2α-benzoyloksy-5β,20-epoksy-1β-hydroksy-7β,10β-dimetoksy-9-okso-11-taxen-13α-yl(2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylpropionat. NO327296B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115401A EP0982027A1 (en) 1998-08-17 1998-08-17 Taxoid derivatives for treating abnormal cell proliferation of the brain
US9958198P 1998-09-08 1998-09-08
PCT/EP1999/006291 WO2000009120A1 (en) 1998-08-17 1999-08-13 New use of taxoid derivatives

Publications (3)

Publication Number Publication Date
NO20010654D0 NO20010654D0 (no) 2001-02-07
NO20010654L true NO20010654L (no) 2001-02-07
NO327296B1 NO327296B1 (no) 2009-06-02

Family

ID=26149540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010654A NO327296B1 (no) 1998-08-17 2001-02-07 Ny medisinsk anvendelse av 4α-acetoksy-2α-benzoyloksy-5β,20-epoksy-1β-hydroksy-7β,10β-dimetoksy-9-okso-11-taxen-13α-yl(2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylpropionat.

Country Status (19)

Country Link
US (1) US6346543B1 (no)
EP (1) EP1109547A1 (no)
JP (1) JP5354762B2 (no)
KR (1) KR100710533B1 (no)
AU (1) AU766168B2 (no)
BG (1) BG65365B1 (no)
CA (1) CA2340921C (no)
CZ (1) CZ293959B6 (no)
EE (1) EE04903B1 (no)
HU (1) HU230235B1 (no)
ID (1) ID27545A (no)
IL (1) IL141238A0 (no)
ME (1) ME00533B (no)
NO (1) NO327296B1 (no)
NZ (1) NZ509965A (no)
RS (1) RS52011B (no)
SK (1) SK285212B6 (no)
TR (1) TR200100557T2 (no)
WO (1) WO2000009120A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
JP2003530838A (ja) * 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質
WO2002097038A2 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
CA2484556A1 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
EP2331140B1 (en) 2008-08-11 2018-07-04 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
MY164086A (en) 2009-10-29 2017-11-30 Aventis Pharma Sa Novel antitumoral use of cabazitaxel
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
JP6025861B2 (ja) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法
NZ628565A (en) * 2012-02-10 2016-03-31 Aventis Pharma Sa New pediatric uses of cabazitaxel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5481018A (en) 1995-03-31 1996-01-02 The Dow Chemical Company Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides

Also Published As

Publication number Publication date
RS52011B (sr) 2012-04-30
BG105264A (en) 2001-11-30
US6346543B1 (en) 2002-02-12
EE04903B1 (et) 2007-10-15
NZ509965A (en) 2003-09-26
EP1109547A1 (en) 2001-06-27
NO20010654D0 (no) 2001-02-07
CA2340921A1 (en) 2000-02-24
ID27545A (id) 2001-04-12
IL141238A0 (en) 2002-03-10
WO2000009120A1 (en) 2000-02-24
CA2340921C (en) 2009-01-06
KR100710533B1 (ko) 2007-04-23
HUP0103748A3 (en) 2003-01-28
AU766168B2 (en) 2003-10-09
JP5354762B2 (ja) 2013-11-27
BG65365B1 (bg) 2008-04-30
CZ2001604A3 (en) 2001-06-13
NO327296B1 (no) 2009-06-02
EE200100079A (et) 2002-08-15
JP2002522490A (ja) 2002-07-23
KR20010085396A (ko) 2001-09-07
SK285212B6 (sk) 2006-09-07
YU7901A (sh) 2003-12-31
SK2302001A3 (en) 2001-09-11
TR200100557T2 (tr) 2001-07-23
HUP0103748A2 (hu) 2002-04-29
CZ293959B6 (cs) 2004-08-18
WO2000009120A8 (en) 2001-04-05
ME00533B (me) 2011-10-10
AU5741999A (en) 2000-03-06
HU230235B1 (hu) 2015-10-28

Similar Documents

Publication Publication Date Title
NO995852L (no) Ny form av S-omeprazol
NO20005503D0 (no) Ny anvendelse
AR028567A1 (es) Nuevos derivados de fenil-propargileter
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
NO20002443D0 (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
EE04849B1 (et) Asendatud fenüülderivaadid, nende valmistamine jakasutamine
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DE69903143D1 (de) Chromanon und thiochromanon derivate
NO20010654L (no) Ny anvendelse av taxoidderivater
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
NO20011491D0 (no) Reduksjon av oksidative stress faktorer
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
NO944906D0 (no) Ny anvendelse av benzo[gÅkinolinderivater
NO20010655D0 (no) Ny anvendelse av taxoidderivater
NO20005483D0 (no) Ny sammensetning
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
BR9508669A (pt) Novos derivados de taizoloÚ3,2-a¾quinolina e naftirina
FI991385A0 (fi) Petun uusi käyttö
FI991397A0 (fi) Petun uusi käyttö
FI980636A0 (fi) Foerfarande och anordning vid installering av en golvbrunn
NO20006392D0 (no) Anvendelse av cytoprotektive midler

Legal Events

Date Code Title Description
MK1K Patent expired